Jordi Llinares-Garcia

Jordi Llinares is the head or orphan medicines at the European Medicines Agency (EMA).

He is responsible for the group assessing applications for orphan designation and coordinates the activities necessary for the adoption of opinions on orphan designation, including the drafting of summary reports and supports the secretariat of the Committee for Orphan Medicinal Products (COMP).

Dr. Llinares joined the EMA in 2002. Prior to joining the EMA, Dr Llinares worked as clinical pharmacologist at Hospital de Sant Pau (Barcelona) and collaborated with the Spanish Drugs Agency as clinical assessor. Dr Llinares was a member of the Ethics Committee of the Institut d’Assistencia Sanitaria (Salt).

Dr. Llinares graduated as an MD from the University of Barcelona and specialised (MIR) as clinical pharmacologist at Hospital Vall d’Hebron (Barcelona). Dr Llinares holds a Masters in Science in Epidemiology from the London School of Hygiene and Tropical Medicine (London).

The voice of rare disease patients in EuropeEURORDIS The international voice of people living with rare diseasesRare Disease International Bringing together patients, families and experts to share experiences in a moderated multi-language forum. RareConnect The Rare Barometer Programme is a EURORDIS initiative that carries out surveys to transform rare disease patients' experiences into figures and facts that can be shared with decision-makers.Rare Barometer An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases